Skip to main content
OpenTrials
Completed

NCT Number: NCT01995435

Refraction Determination Analysis

Correlating the accuracy of a refraction done over telemedicine to that of a standard refraction, with a study hypothesis that the results will be equivalent.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–40 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18-40 years old
  • healthy eyes

Exclusion criteria

  • mid level ocular diseases (glaucoma, hypertension, retinal issues)
  • psychiatric disorders
  • brain tumor or history of
  • under 18, or over 40 years old

Treatment and study plan

Telemedicine refraction

Device

Other names: Glasses,, Contact lenses,, Refractive surgery,

Traditional refraction

Device

Primary outcomes

  1. refraction in diopters over telemedicine compared standard phoropter refraction

    Time frame: an average of 1 year

Secondary outcomes

  1. telemedicine refraction results beyond dioptric readings

    Time frame: an average of 1 year

    to see if there are other uses for telemedicine refraction results

Other outcomes

  1. patient satisfaction from telerefraction

    Time frame: an average of 1 year

Sponsors and collaborators

Lead sponsor

Lee, Steven, M.D.

Indiv

Registry information

Important dates

Study start
2015
Primary completion
2015
Study completion
2015
First posted
Nov 26, 2013
Registry last updated
Sep 7, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.